Blog

New therapeutic target found for aggressive pediatric cancers with few treatment options

Mar . 19 . 2019

First-line Pembrolizumab Monotherapy

Mar . 19 . 2019

Keynote 427 Cohort B results demonstrate promising anti-tumor activity with first-line pembrolizumab monotherapy in non-clear cell advanced RCC.

ASCO GU 2019: Analysis of Overall Survival Based on Early Tumor Shrinkage in the Phase III METEOR Study of Cabozantinib versus Everolimus in Advanced Renal Cell Carcinoma

Mar . 18 . 2019

ASCO GU 2019: Genetic Evolution of Metastatic Renal Cell Cancer

Mar . 18 . 2019

Merck Highlights Breadth of Immuno-Oncology Research Program in Genitourinary Cancers at ASCO GU

Mar . 12 . 2019

Aerobics, Strength Exercises Improve Quality of Life in Kidney Cancer Survivors

Mar . 12 . 2019

Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer

Mar . 08 . 2019

Comparative study of renal cell carcinoma in patients less than 40 years of age and older age patients: A retrospective single-center study

Mar . 06 . 2019

Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study

Mar . 06 . 2019

If Someone in Your Life Just Survived Cancer, Here’s How You Can Support Them Now

Mar . 05 . 2019

« Previous 1 … 51 52 53 54 55 56 Next »